Consolidation

(Artisanova/iStock via Getty Images Plus)

Advarra acquires Longboat

By Jenni Spinner

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

(RG-vc/iStock via Getty Images Plus)

Advarra purchases IntegReview IRB

By Jenni Spinner

The institutional review board services provider has acquired the AAHRPP-accredited central IRB, which specializes in early-phase research.

(Artsanova/iStock via Getty Images Plus)

Syneos Health to acquire Synteract

By Jenni Spinner

With the purchase, Syneos Health seeks to strengthen connections with the rapidly growing pre-revenue biopharmaceutical market, and expand global reach.

(monsitj/iStock via Getty Images Plus)

People on the Move: August 2020

By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

(Image: Getty/Manop1984)

PCI acquires Bellwyck Pharma Services

By Jenni Spinner

The purchase follows PCI’s plans to expand its clinical trial services globally, including in North America and Europe.

(Image: Getty/fizkes)

Three companies combine to form consulting CRO

By Vassia Barba

Aiming to support drug developers in issues related to market insights, engagement, and access, Synaptiq enters the market backed by three consultancy agencies.

(Image: Getty/kritchanut)

Guest column

M&A in the CRO industry: The Good, The Bad, and The Ugly

By Matthew Barrows, senior business consultant

M&A is a huge part of the CRO space. Inorganic growth has long been the go-to strategy for any CRO and we’re never surprised to see this month’s latest deal. However, I’d like to challenge the idea that this is always the best way to grow a CRO business.

(Image: Getty/martince2)

SCOPE 2018

A CRO monopoly? Sponsors frustrated with lack of options

By Melissa Fassbender

With fewer global mid-sized contract research organizations (CRO) through consolidation, some stakeholders are expressing concern that the industry could become a monopoly – “we may be getting there,” one expert said.

GettyImages/maxsattana

Charles River to buy MPI Research for $800m

By Flora Southey

Charles River Laboratories International says it is en route to ‘double its size in five years’ with the acquisition of non-clinical CRO MPI Research.

(Image: iStock/manaemedia)

INC Research/inVentiv now Syneos Health

By Melissa Fassbender

INC Research/inVentiv Health is starting the new year with a rebrand after merging to create one of the largest biopharmaceutical outsourcing providers in 2017.

Follow us

Products

View more

Webinars